U.S. Rep. Bob Inglis (R-SC) expressed disappointment as the National Institute of Health issued final guidelines this week describing which embryonic stem cell lines will be eligible for government funding, effectively expanding the universe of stem cells that can be used for research.
Link to this comment:
All Comments (0)